🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1b/2, Randomized, Double-blind, Placebo-Controlled, Multiple Oral D...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02078310
The study will evaluate the efficacy and safety of ITI-007 (Lumateperone) i...
Status
Completed
Location
Clinical Site
Start Date
2015-12-15
Trial ID
NCT02600494
Treatments Being Tested
The purpose of this study is to determine the relationship between ITI-007 ...
Status
Completed
Location
Johns Hopkins Medical Institutions
Start Date
2014-10
Trial ID
NCT02288845
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy and tolerab...
Status
Recruiting
Location
CSTrials
Start Date
2026-04-18
Trial ID
NCT07734103
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled study comparing the ...
Status
Terminated
Location
Multiple Locations
Start Date
2016-08-29
Trial ID
NCT02817906
The study will evaluate the antipsychotic efficacy of ITI-007 in a randomiz...
Status
Completed
Location
Clinical Site
Start Date
2015-06
Trial ID
NCT02469155
Treatments Being Tested
The purpose of this study is to offer open label ITI-007 treatment to patie...
Status
Terminated
Location
New York State Psychiatric Institute
Start Date
2019-03-01
Trial ID
NCT03817528
Treatments Being Tested
The study will evaluate the efficacy and safety of ITI-007 in a randomized,...
Status
Completed
Location
Clinical Site
Start Date
2017-11-27
Trial ID
NCT03249376
Treatments Being Tested
The study will evaluate the efficacy and safety of ITI-007 adjunctive to li...
Status
Completed
Location
Clinical Site
Start Date
2016-03-07
Trial ID
NCT02600507
Treatments Being Tested